Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01068340 · ClinicalTrials.gov registry record

Early Small Bowel Obstruction Following Laparotomy For Trauma

A clinical trial, sponsored by University of Southern California.

Completed
Registry status
571
Enrollment target

NCT01068340: Completed study, sponsored by University of Southern California.

NCT01068340 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 571 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01068340 has completed, sponsored by University of Southern California.

COMPLETED
Registry status
571 participants
Enrollment target

Study Summary

The formation of intraperitoneal adhesion following abdominal surgery is accepted by clinicians as an inevitable consequence. More than 90% of patients undergoing a surgical procedure in the abdomen will develop intraperitoneal adesions. The incidence however, of small bowel obstruction (SBO) resulting form these adhesions is far lower. To date, it is unknown which risk factors predispose these patients to develop SBO. Several have been proposed, such as age, peritonitis, or surgery for small bowel injury resulting from gunshots. None of them however, has been widely accepted. During the last 20 years the significant lifetime risks associated with this phenomenon and its impact on the quality of life of patients has been well recognized. In addition, the burden on healthcare resources due to complications caused by adhesions is increasing and medicolegal consequences are rapidly evolving. Early SBO following laparotomy for trauma is a poorly described entity. A few retrospective, single institution studies with a low number of patients have tried to address this issue. However, these studies either included a subset of trauma patients, i.e. patients sustaining penetrating trauma,\[4\] or patients undergoing a negative or non-therapeutic laparotomy, or examined only the incidence of SBO requiring surgical intervention. In addition, recent data regarding this issue is lacking, especially after the implementation of the damage control concept and the other advances in trauma surgery. The aim of this study is to define the incidence of early SBO following laparotomy for trauma and to examine possible risk factors associated with its development.

Trial Details

FieldValue
Enrollment Target 571 participants
Start Date 2010-01
Est. Completion 2010-06
University of Southern California

617 total trials

What the finished NCT01068340 record still lists

NCT01068340 is an observational study that tracks outcomes without assigning an intervention. The registered 571 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01068340 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01068340 about?

NCT01068340 is a clinical study titled "Early Small Bowel Obstruction Following Laparotomy For Trauma". The formation of intraperitoneal adhesion following abdominal surgery is accepted by clinicians as an inevitable consequence. More than 90% of patients undergoing a surgical procedure in the abdomen will develop intraperitoneal adesions. The incidence however, of small bowel obstruction (SBO) result...

What is the current status of trial NCT01068340?

This trial is currently completed. The enrollment target is 571 participants. The study started on 2010-01. Estimated completion is 2010-06.

Who is sponsoring clinical trial NCT01068340?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04410796 · 571 participants · Phase 2

    Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

  • NCT05131022 · 572 participants · Phase 1

    A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • NCT06346392 · 572 participants · Phase 3

    AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

  • NCT06615050 · 572 participants · Phase 3

    A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01068340, the US trial registry maintained by the National Library of Medicine. NCT01068340 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.